Skip to content

Key takeaways

  • While the macro backdrop has improved, we believe risky assets are priced too optimistically. At a portfolio level, we remain slightly defensive.
  • However, some risky assets have lagged the broader market rally and appear attractive, specifically, US small capitalization stocks (small caps) and emerging market (EM) equities.
  • We explore some rationale for the performance lag in these two areas. Ultimately, we believe much of the bad news is priced-in, and catalysts are on the near horizon. We think these two assets offer positive asymmetry and are a smart place to add risk in multi-asset portfolios.

Are investors too optimistic?

In some regions, including the United States, the macro backdrop has been improving. Growth remains resilient, with strong service sector activity and a stabilizing manufacturing environment. Inflation continues to abate, with inflation surprises near three-year lows. Federal Reserve (Fed) policy is restrictive, but the odds of “peak Fed” rates have grown substantially over recent months. Overall, the probability of a soft landing has certainly risen. 

How are asset prices reacting to this news? Risky assets—such as equities and high-yield credit—did not wait for the “all clear” sign from macro-land. Their rally began nearly a year ago in October 2022 at the first signs of a peak in inflation, but well before a substantial improvement in growth or monetary policy. Most equity markets have achieved bull market status, while corporate bond spreads are near cyclical tights.   

The challenge today is that most risky assets have rallied ahead of both the current and projected macro environment (see Exhibit 1). In our view, most risky assets are pricing in macro expectations that are overly optimistic. While the macro backdrop has improved, we still believe there is considerable uncertainty over what lies ahead next year.

Exhibit 1: Risky assets are overly optimistic

Global Manufacturing Purchasing Managers Index (PMI) vs. Cross Asset Performance 
Returns as of September 2023. PMI data as of August 2023.

Sources: Bloomberg, MSCI, Macrobond. Cross asset returns are measured as a year-over-year percentage difference between the MSCI ACWI Index and the Bloomberg Global Aggregate Total Return Index Value Unhedged USD, at a monthly frequency. Indexes are unmanaged and one cannot directly invest in them. They do not include fees, expenses or sales charges. Past performance is not an indicator or a guarantee of future results. MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI. Important data provider notices and terms available at www.franklintempletondatasources.com.

The mispricing of risky assets is a key reason why we remain slightly defensive at the portfolio level. We favor fixed income over equities, where it is now relatively easy to find high-quality bonds yielding over 5% with little duration or credit risk.

Where to add risk in multi-asset portfolios

While most global equity markets have rallied since last October, not every index has performed equally. We examine equity pairings that historically perform well when growth is beginning to improve from below-trend levels, which is the environment many regions are in today (see Exhibit 2). While some parts of the equity market have performed well—cyclicals and growth stocks—other parts have lagged considerably, namely US small caps and emerging markets. 

Exhibit 2: What Has Outperformed During the Most Recent Equity Rally?

Relative Equity Performance Since October 2022
September 30, 2022–September 6, 2023

Sources: Bloomberg, Organisation for Economic Co-operation and Development (OECD), Macrobond. Index representations: Small cap = Russell 2000 Index. Large Cap = Russell 1000 Index. Emerging = MSCI Emerging Markets Index. Developed = MSCI World Index. US Cyclicals = MSCI USA Cyclical Sectors Price Return USD Index. Defensives = MSCI USA Defensive Sectors Price Return USD Index. EAFE = MSCI EAFE Net Total Return USD Index. US = MSCI USA Net Total Return USD Index. Growth = Russell 1000 Growth Index. Value = Russell 1000 Value Index. Indexes are unmanaged and one cannot directly invest in them. They do not include fees, expenses or sales charges. Past performance is not an indicator or a guarantee of future results. MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI. Important data provider notices and terms available at www.franklintempletondatasources.com.

It is not hard to rationalize why these equity markets have lagged.

US small cap stocks are generally more sensitive to higher interest rates, due to a larger amount of variable rate debt and weaker balance sheets (i.e., lower interest coverage ratios). Plus, exposure to the artificial intelligence (AI) theme and the “magnificent 7” group of technology stocks is much more limited within small caps. In emerging markets, China’s economy continues to struggle for momentum, and more broadly, we have observed a weak global manufacturing environment.

The good news is that these risks appear to be largely priced in. Valuation ratios, like price-to-earnings or price-to-book, suggest these assets are attractively valued. However, valuations are not good tactical indicators. Therefore, we identify some key catalysts that are developing in support of US small caps and emerging market equities that we believe markets have yet to fully reflect. 

US small caps

  • US interest rates are unlikely to move much higher from here. Historically, rate increases have had a lagged effect, with Treasury yields lower a year following the end of the Fed’s rate-hike cycle. Typically, performance for small cap stocks one year following the Fed’s final rate hike in the cycle has been robust.
  • Small-cap stock performance has historically benefited from falling inflation. 
  • Small caps tend to outperform when leading indicators recover from below-trend, which our team believes is currently taking place.

Emerging markets

  • Some measures of relative growth, like manufacturing PMIs, suggest stronger growth for EMs over developed markets (DMs).
  • Some leading indicators of global manufacturing are also rebounding. Along with rising AI demand, this trend should bode well for semiconductors (see Exhibit 3), a key export for EM Asia (Taiwan and South Korea). According to the World Trade Semiconductor Statistics, global semiconductor sales are forecast to grow by 11.8% in 2024.1
  • China’s policy environment is showing signs of proactiveness. In September alone, more than 30 provinces and cities have enhanced property policies to support growth.
  • Disinflation is prevalent across many EM countries after strong rate hiking cycles. Over the next year, we expect policy easing to be more supportive compared to DM markets.

Exhibit 3: Leading Manufacturing Indicators Should Improve Semiconductor Sales

Global Manufacturing and Semiconductor Cycles 
January 1998–July 2023

Sources: Economic Cycle Research Institute (ECRI), Semiconductor Industry Association (SIA), Macrobond. ECRI data was advanced four months in order to maximize its correlation with semiconductor sales. Important data provider notices and terms available at www.franklintempletondatasources.com.

Putting it all together

We remain slightly defensive at the portfolio level due to the general expensiveness of risky assets, like equities and high yield credit, especially relative to many developed market government bonds. However, we have shown that not all equity markets seem expensive; US small caps and emerging markets have attractive valuations, in our view. Additionally, they are geared to an improving macro environment, have near-term catalysts, and can offer positive performance asymmetry over the next year. Overall, we think US small caps and emerging markets are smart places to add risk in multi-asset portfolios. 



IMPORTANT LEGAL INFORMATION

This material is provided for general informational purposes only and should not be considered individualized investment advice, a recommendation or a solicitation to adopt any investment strategy. It does not constitute legal or tax advice. Franklin Templeton accepts no liability for losses arising from use of this material.

The views expressed are those of the investment manager as of the publication date and may change without notice. These opinions and analyses are based on certain assumptions, including market conditions that may change. They may differ from those of other portfolio managers or from the firm as a whole.

This material is not intended to provide a complete analysis of all material facts regarding any country, region or market. No assurance can be given that any forecast, projection or prediction regarding economies or financial markets will be realized. References to specific securities are for illustrative purposes only and should not be interpreted as recommendations or a solicitation to buy, sell, or hold any security.

Any research or analysis in this material has been prepared by Franklin Templeton for its own purposes and is provided incidentally. While the information included is believed to be reliable, its accuracy and completeness cannot be guaranteed, and it is subject to change without notice.

Past performance does not guarantee future results, or any profit or gain. All investments involve risks, including possible loss of principal.

Franklin Templeton offers environmental, social and governance (ESG) capabilities, though not all strategies or products incorporate ESG as part of the investment process.

Investment strategies and services may not be available in all jurisdictions. Please consult your financial professional or Franklin Templeton contact for further information.

Brazil: Issued by Franklin Templeton Brasil Ltda. Canada: Issued by Franklin Templeton Investments Corp. Offshore Americas: In the United States, this publication is made available by Franklin Templeton. United States: Issued by Franklin Templeton. Investments are not FDIC insured; may lose value; and are not bank guaranteed.

Europe: Issued by Franklin Templeton International Services S.à r.l., 8A, rue Albert Borschette, L-1246 Luxembourg. Poland: Issued by Templeton Asset Management (Poland) TFI S.A.; Rondo ONZ 1; 00-124 Warsaw.  Saudi Arabia: Issued by Franklin Templeton Financial Company, 13512 Riyadh, Saudi Arabia. Regulated by CMA. License no. 23265-22. South Africa: Issued by Franklin Templeton Investments SA (PTY) Limited, which is authorised by the FSCA as a Financial Service Provider (No.44475). Switzerland: Issued by Franklin Templeton Switzerland Ltd, Talstrasse 41, CH-8001 Zurich. Middle East & Africa (ex South Africa): Issued by Franklin Templeton Investments (ME) Limited, which is regulated by the Dubai Financial Services Authority. Address: Franklin Templeton, The Gate, East Wing, Level 2, Dubai International Financial Centre, P.O. Box 506613, Dubai, U.A.E. Tel: +971(04) 428 4100. United Kingdom: Issued by Franklin Templeton Investment Management Limited (FTIML), registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL.

Australia: Issued by Franklin Templeton Australia Limited (ABN 76 004 835 849) (Australian Financial Services License Holder No. 240827), Level 47, 120 Collins Street, Melbourne, Victoria 3000. Hong Kong: Issued by Franklin Templeton Investments (Asia) Limited. Japan: Issued by Franklin Templeton Japan Co., Ltd. South Korea: Issued by Franklin Templeton Investment Advisors Korea Co., Ltd. Malaysia: Issued by Franklin Templeton Asset Management (Malaysia) Sdn. Bhd. & Franklin Templeton GSC Asset Management Sdn. Bhd. Singapore: Issued by Templeton Asset Management Ltd. (UEN) 199205211E. 2 Central Boulevard, IOI Central Boulevard Towers, West Tower #34-01, Singapore 018916.

Access your local website at www.franklinresources.com/all-sites.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.

Copyright © 2026 Franklin Templeton. All rights reserved.